Five μm tissue slides were sectioned on APES coated slides, and deparaffinized utilizing xylene (2x10min) and ethanol (2x5min). The slides were rinsed with PBS before blocking with 0.3% H2O2 for 30 min. In-situ hybridization for EBV encoded RNA (EBER) was performed with the Novocastra™ Epstein-Barr virus ISH Kit using standard methods [14]. Monoclonal antibodies to the HLA-class I heavy chain (HC-10, kindly provided by prof. dr. J. Neefjes, the Netherlands Cancer Institute, Amsterdam, the Netherlands) and polyclonal rabbit anti human B2 microglobulin (B2M, DAKO, Glostrup, Denmark), at dilutions of 1:500 and 1:400 respectively, were used to mark HLA class I expression. Monoclonal antibody to CR3/43 (DAKO) that binds to the HLA-II chain of HLA-DP, HLA-DQ, and HLA-DR at a dilution of 1:200 was used to mark HLA class II expression. CD30 was used to aid in identifying HRS cells. Tissues were stained using the Leica Bond 3 staining platform. Scoring for EBER and HLA expression was performed if at least 50 HRS cells were present in all three cores combined. A case was considered positive for HLA if there was membranous staining in more than 50% of the HRS cells.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.